Human Cytomegalovirus (CMV) is a herpesviruses which frequently causes life-threatening infections in AIDS patients and other immunocompromised individuals. Preliminary studies suggest that CMV may augment human immunodeficiency virus (HIV) gene expression and replication and thus contribute to the development of AIDS in an HIV-infected individual. The converse interaction, activation of CMV gene expression by HIV, may be pertinent to the occurrence of unusual and severe CMV infections in AIDS patients. This proposal is designed to elucidate the direct molecular interactions of these two viruses. HIV regulatory sequences which respond to CMV infection will be identified and precisely mapped using transient assays. The level(s) of gene expression affected by such signals will be characterized by a comprehensive analysis of alterations in transcription, processing, stability, nuclear/cytoplasmic transport and translation conferred on a transcript by HIV cis-acting signals. The CMV gene products responsible for altering HIV gene expression will be identified and characterized. The converse interaction, the effects of HIV on CMV-regulated gene expression, will also be investigated. Cis-acting signals that mediate such effects will be defined. The mechanisms through which these signal operate will be characterized by analyses of transcription and translation. The role of specific HIV genes, particularly the regulatory genes tat and art/trs will be determined. Finally after the signals, factors and mechanisms involved in the response of one virus to the reciprocal virus have been delineated, the role of combined infection on expression regulated by these signals will be determined. These studies will reveal new insights into the molecular pathogenesis of AIDS.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Harrington, R D; Geballe, A P (1996) Human immunodeficiency virus type-1 susceptible whole cell and microcell hybrids. Ann Clin Lab Sci 26:522-30
Geigenmuller, U; Linial, M L (1996) Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5' HIV-1 genomic RNA sequence. J Virol 70:667-71
Adams, M; Sharmeen, L; Kimpton, J et al. (1994) Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci U S A 91:3862-6
Lee, P P; Linial, M L (1994) Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J Virol 68:6644-54
Lewis, P F; Emerman, M (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68:510-6
Garcia, J V; Miller, A D (1994) Retrovirus vector-mediated transfer of functional HIV-1 regulatory genes. AIDS Res Hum Retroviruses 10:47-52
To, R Y; Booth, S C; Turk, G et al. (1994) Completion of avian retroviral DNA replication intermediates inhibited by antisense RNA. Virology 200:336-46
Garcia, J V; Alfano, J; Miller, A D (1993) The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J Virol 67:1511-6
Harrington, R D; Geballe, A P (1993) Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J Virol 67:5939-47
Geballe, A P; Gray, M K (1992) Variable inhibition of cell-free translation by HIV-1 transcript leader sequences. Nucleic Acids Res 20:4291-7

Showing the most recent 10 out of 19 publications